Orion’s mission is to build well-being. To this end, Orion provides pharmaceuticals and diagnostic tests that help patients to effectively treat their diseases. Effective drugs also provide added value for patients by improving quality of life.
 
Orion wants to be an innovative European R&D-based pharmaceutical and diagnostic company with a special emphasis on developing medicinal treatments and diagnostic tests for the global markets. Innovation is at the centre of Orion’s vision, because the development of innovative products alone is not enough in the current competitive environment: the company’s overall approach should be based on innovation. Orion is aiming at innovative, effective practices and business models throughout its operations.
 
Orion’s values are Mutual trust and respect, Customer focus, Innovation, Achievement as well as Quality, reliability and safety. These are the basic elements behind the implementation of our strategy.  
 
Orion’s strategic aims are profitable growth and increased shareholder value, whilst keeping business risks under control. Orion´s strategy focuses on three key themes: 

1. Growth of business operations through a competitive product portfolio
2. Strengthening the market position in Europe
3. Improving the flexibility and efficiency of operations

 
All of Orion’s business divisions have a major role in achieving the financial objectives of the Group, but the two largest divisions, Proprietary Products and Specialty Products, are crucial. Orion strives to enhance synergies between patent-protected proprietary drugs, off-patent (i.e. generic) prescription drugs and self-care products.